The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine – United States December 2020

Oliver, S., Gargano, J., Marin, M., et al.. (2020). The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine – United States, December 2020. (Added 12/30/2020.) Morbidity and Mortality Weekly Report 69(50);1922-1924..
This report documents the rationale supporting ACIP’s interim recommendation to use the Pfizer BioNTech vaccine in persons age 16 and older.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.